
Megtios 400mg Tablet ER
Marketer
Ridhima Biocare
Salt Composition
Etodolac (400mg)
Overview Megtios 400mg Tablet ER
Arthritis and acute pain can be effectively managed with the extended-release Megtin 400mg tablet, a potent analgesic. This medication reduces both pain and inflammation in conditions such as rheumatoid and osteoarthritis. Always follow your physician's instructions regarding dosage and treatment duration. Taking it with food or milk minimizes the risk of gastrointestinal discomfort. Pre-existing heart conditions or a history of stroke should be disclosed to your doctor. Commonly reported side effects include nausea, vomiting, indigestion, and abdominal pain; dizziness, drowsiness, and visual impairment may also occur. For prolonged therapy, regular monitoring of kidney and liver function, along with blood work, is usually recommended by your doctor. Protracted use carries potential risks, including serious complications like gastrointestinal bleeding and renal impairment.
Primary Ingredients of Megtios 400mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Megtios 400mg Tablet ER
Analgesia
Major Benefits of Megtios 400mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Megtios 400mg Extended-Release tablet should be taken with a meal.
Common Side effects of Megtios 400mg Tablet ER:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Dizziness
- Drowsiness
How to use Megtios 400mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Megtios 400mg Extended-Release tablet without chewing, crushing, or breaking it. Administer this medication with a meal.
How Megtios 400mg Tablet ER works:
Mefenamic acid 400mg extended-release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and the associated inflammatory response, characterized by redness and edema.
SAFETY ADVICE
AlcoholUNSAFE
Combining Megtios 400mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Megiots 400mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Megiots 400mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Extended-release MegtIos 400mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Megtios 400mg tablets are likely safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, though further research is warranted. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Megtios 400mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megtios 400mg Tablet ER :
Should you forget to take a Megtios 400mg Extended-Release tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Megtios 400mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Indole Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
